Authors:
Rozenbaum, W
Katlama, C
Massip, P
Bentata, M
Zucman, D
Delfraissy, JF
Trepo, C
David, F
Lanier, ER
Vavro, C
Mamet, JP
Citation: W. Rozenbaum et al., Treatment intensification with abacavir in HIV-infected patients with at least 12 weeks previous lamivudine/zidovudine treatment, ANTIVIR TH, 6(2), 2001, pp. 135-142
Authors:
Raffi, F
Reliquet, V
Ferre, V
Arvieux, C
Hascoet, C
Bellein, V
Besnier, JM
Breuz, JP
Garre, M
May, T
Molina, JM
Perre, P
Raguin, G
Rozenbaum, W
Zucman, D
Citation: F. Raffi et al., The VIRGO Study: nevirapine, didanosine and stavudine combination therapy in antiretroviral-naive HIV-1-infected adults, ANTIVIR TH, 5(4), 2000, pp. 267-272
Authors:
Dupont, C
Vasseur, E
Beauchet, A
Aegerter, P
Berthe, H
de Truchis, P
Zucman, D
Rouveix, E
Saiag, P
Citation: C. Dupont et al., Long-term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients, AIDS, 14(8), 2000, pp. 987-993
Citation: P. Honderlick et al., Interpretation of high levels of HIV-1 RNA in the cerebrospinal fluid (CSP) using amplicor HIV-D monitor test, PATH BIOL, 47(5), 1999, pp. 560-562